Our discoveries pave the way for earlier diagnoses, better treatments, and healthier lives.
Centrally managed core technology platforms equipped with leading tools to enable researchers ask bold questions—and find game-changing answers.
Actively involving patients, support-givers, teachers, and pupils to ensure research reflects public perspectives and has real-world impact
Join a vibrant, interdisciplinary community where innovation meets mentorship
Enabling the translation of research in a world-class ecosystem for innovation that drives enterprise development.
Dr Alison Reynolds accepts the winning trophy for the 2025 UCD VentureLaunch Accelerator Programme on behalf of the team involved in OcuHealth, an emerging eye therapeutics start-up.
Ursula Ledwith, presenter of the Arts Programme on community radio station RosFM, opened the final leg of the 2025 exhibition tour merging art, science, and community.
Conway Fellows, Professors Geraldine Butler and Wenxin Wang and Dr Martina Wallace receive Research Ireland Frontiers for the Future programme awards
PhD student, Louise Keegan received the inaugural Crean travel bursary award at the 2025 UCD Conway Festival of Research & Innovation for her work on the impact of cocaine exposure on the development of the prenatal brain.
Minister for Health, Jennifer Carroll MacNeill TD, has appointed Professor Helen Roche to the Board of the Food Safety Authority of Ireland (FSAI) with effect from 7 October 2025 until 6 October 2028.
Dr Tess McCann has won the 2025 UCD Conway Festival Gold Medal for published research describing the discovery of a mutation in a gene called emc1 that causes major vision problems in zebrafish.
Spotlighting 'Cut from the Same Cloth', a public engagement project led by UCD Conway Institute at the launch of the 2023/2024 UCD Community Engagement Report.
The findings of an international study including Prof. Niamh Nowlan is published in the current issue of Nature and lays the developmental and genetic groundwork for the human-defining trait of bipedalism.
Findings from a decade-long international study reported in Nature Metabolism has shown that the source of dietary fat can change how well key immune cells work in obesity.
The development of new drugs based on targeting non-coding RNA can produce less toxic, and more specific therapies for cancers and diseases.
Fruit flies are tiny creatures, but the questions we are asking – how do neurons fail, how to fix them – are massively important for MND research.
Deciphering the links between the brain, gut and obesity is challenging how obesity has been thought of and treated in our society.
The World Health Organisation (WHO) estimates that by 2050, there could be 50 million deaths annually due to antibiotic resistance. Professor Siobhán McClean is fighting to tackle some of these drug-resistant pathogens threatening so many lives.
Osteosarcoma, a rare, deadly paediatric bone cancer has defied new approaches to its treatment ever since chemotherapy was introduced in the 1970s. Dr Fiona Freeman aims to change that.
Working in parallel on two new game changing technologies that will enable quicker, safer, less painful and more precise micro-biopsies and visualise changes in individual cells caused by disease.
The level of low-grade, chronic inflammation in the body is a better indicator of metabolic health than simply measuring body mass index, or BMI.
Preventing the GI tract springing a leak by developing new drug treatments that reinforce the epithelial layer.
Oxygen sensing in health and disease: What have we learnt so far?
Magnetic actuation of ferritin-functionalized micro-cantilevers: investigating the feasibility of magnetic ion channel gating
Genomic complexity as a therapeutic vulnerability in leiomyosarcoma